Home » Topics » BioWorld Science

BioWorld Science
RSS

Revolution Medicines advances potent, orally available SHP-2 allosteric inhibitor

March 28, 2018

ACT-539313 safe and well tolerated in first-in-human study

March 27, 2018

New Toll-like receptor 7/8 agonists patented by GlaxoSmithKline

March 27, 2018

RaQualia receives milestone payment from EA Pharma

March 27, 2018

Gilead identifies novel Toll-like receptor 8 modulators

March 27, 2018

Velcade approved in Japan for primary macroglobulinemia and lymphoplasmacytic lymphoma

March 27, 2018

AdPueriVitam discovers novel NMDA receptor antagonists

March 27, 2018

Jiangsu Hengrui Medicine Co., Shanghai Hengrui Pharmaceutical Co. patent factor XIa inhibitors

March 27, 2018

Nippon Kayaku obtains Japanese approval for trastuzumab biosimilar

March 27, 2018

Bayer Pharma divluges new adenosine receptor A2B antagonists

March 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...